Bimeda Holdings Chairman, Donal Tierney, Minister for Enterprise, Trade and Employment, Simon Coveney TD, and Professor Helen Roche, interim UCD Vice-President for Research, Innovation and Impact toda...
Bimeda is pleased to announce the appointment of Jim Lovin as a Strategic Accounts Manager - Swine. Jim will focus on the development and management of both core Bimeda products and custom vaccine lin...
Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...
Bimeda is pleased to announce the launch of the company's first Annual Sustainability Report. The report is now available to read and download on onebimeda.com In early 2022, Bimeda announced the laun...
Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...
Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...
It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...
Dear Customers, Distributors and Retailers, Bimeda received communication from the Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM) regarding continued concerns that people ar...
Bimeda is pleased to announce the acquisition of AquaTactics Fish Health ("AquaTactics"), based in Seattle, Washington. The company was founded in 2009 by Dr Tom Goodrich and Hugh Mitchell DVM. The co...
Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and ...
Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ...
Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac...
Bimeda Inc. is pleased to announce the formal renaming of acquired vaccine production, research and diagnostic company, Texas Vet Lab, Inc., as Bimeda Biologicals Inc. Both Texas Vet Lab, Inc. (TVL) a...
We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and ...
Bimeda is happy to welcome Matt Harris as the Vice President of Food Animal Sales & Marketing. He is responsible for the management and development of the entire sales and marketing efforts of the...
Bimeda® is delighted to welcome Chris Engel in the newly created Marketing and Integrator Manager role. In this role, Chris will be focusing on Marketing and branding support for Bimeda and Texas Vet ...
Bimeda® is pleased to announce Rey Armendariz in the new role of Regional Strategic Manager. Effective immediately, Rey will be an integral part of the food animal sales team and assist in the sales d...
Bimeda® is pleased to announce the appointment of David Christian as a Strategic Sales Account Manager for the Livestock Southern Region (Texas, Oklahoma and Eastern New Mexico). David will work as pa...
We would like to congratulate Stephanie Batliner, Director of Regulatory Affairs of North America, on her election to the role of Chair of GADA (Generic Animal Drug Alliance). We would like to c...
Following consistent growth and popularity of Bimeda® lnc.'s Confidence EQ®, the parent company announced plans to expand marketing efforts and packaging options today for the equine appeasing ph...